Again, the lower expression of CR1 in SLE patients did not influence the inhibitory function of the receptor (Figures 2(b) and 2(e)) and the extent of reduction of activation markers was similar to that found in healthy subjects (Figures 2(c) and 2(f)). The gene discussed is CR1; the disease is systemic lupus erythematosus.